skip to content »

Pathology & Immunology

Houston, Texas

Pathology and Immunology
Pathology & Immunology
not shown on screen

Faculty

Jon A. Reed, M.D., F.C.A.P. Professor Emeritus

Clinical Service Area

  • M.D., Pennsylvania State University College of Medicine, Hershey, PA
  • M.S., Biology, Pennsylvania State University, University Park, PA
  • B.S., Microbiology, Pennsylvania State University, University Park, PA

Residency

  • Anatomic Pathology: Yale-New haven Hospital, New Haven, CT

Fellowship

  • Molecular Pathology: University of Oklahoma
  • Health Science Center, Oklahoma City, OK
  • Dermatopathology: New York Hospital-Cornell
  • University Medical Center, New York, NY

Specialty

  • Dermatopathology

Board Certification

  • Anatomic Pathology, 11/1992
  • Dermatopathology, 11/1993

Area of Interest

  • Dermatopathology
  • Melanomag
  • Melanocytic (pigmented) lesions
  • Signal transduction pathways involved in melanocyte differentiation and in melanoma tumor progression

Current Position

  • Professor Emeritus

Professional Positions Held

  • Professor of Pathology and Dermatology; Director Section of Dermatopathology, Baylor College of Medicine; Director, Histology services Laboratory, 2005-Jan 2, 2009
  • Associate Professor of Pathology and Dermatology; Director Section of Dermatopathology, Baylor College of Medicine, 1999-2005
  • Assistant Professor of Pathology, Cornell University Medical College (The Joan and Sanford Weill College of Medicine of Cornell University), 1994-1998

Other Positions

  • Editorial Board, American Journal of surgical Pathology
  • Editorial Board, Journal of Cutaneous Pathology
  • Section Editor Archives of pathology and Laboratory medicine
  • Ad hoc reviewer for 10 additional peer reviewed scientific and medical journals
  • Consultant Medical Staff: Harris Health System / Ben Taub General Hospital

Honors and Awards

  • Named one of America's Best Doctors: 2001-2002; 2003-2004, 2005-2006

Professional Organization Memberships

  • Fellow, College of American Pathologists
  • Fellow, American Society of Dermatopathology
  • Founding Member, Society for Melanoma Research
  • United States and Canadian Academy of Pathology
  • Harris County Medical Society
  • Houston Society of Clinical Pathologists
  • Association of Dermatopathology Fellowship
  • Training Directors
  • Society for Applied Immunohistochemistry: Board of Directors, 1995-2000
  • Pan-American Society for Pigment Cell Research, Program Committee, 2000
  • Invited participant 1st Workshop, Melanoma Research Foundation, 2001
  • Program Director, 45th Annual Symposium Houston Society of Clinical Pathology, 2005

Representative Publications

  • Reed JA, Medrano EE. Recent advances in melanoma. Frontiers in Bioscience 11: 3003 - 3013, 2006
  • Reed JA, Lin Q, Chen D, Mian IS, Medrano EE.
  • SKI pathways inducing progression of human melanoma. Cancer Metastasis Rev 24: 265 - 272, 2005
  • Bales E, Mills L, McGahren M, Bandyopadhyay D, Chen D, Reed JA, Timchenko N, van den Oord JJ, Bar-Eli M, Keyomarsi J, Medrano EE. The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. Cancer Res 65: 692 - 697, 2005
  • Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express markers of the early neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 29: 562 - 568, 2002
  • Trejo O, Reed JA, Prieto VG. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM, AND GAP-43: Evidence of early Schwann Cell Differentiation. J Cutan Pathol 29: 397 - 406, 2002
  • Reed JA, Xu W, Bales E, Bandyopadhyay D, Okan N, Colmenares C, Medrano EE. Overexpression and localization of the oncogenic protein Ski in cutaneous human melanomas: consequences for TGF-ß signaling. Cancer Res 61: 8074 - 8078, 2001
  • Gilhooly EM, Morse-Gaudio M, Bianchi L, Reinhart L, Rose DP, Connolly JM, Reed JA, Albino AP. Loss of expression of protein kinase C ß is a common phenomenon in human malignant melanoma. Melanoma Res 11: 355 - 369, 2001
  • Fullen D, Reed JA, Finnerty B, McNutt NS. S100A6 expression in melanocytic neoplasms. J Cutan Pathol 28: 393 - 399, 2001
  • Reed JA, Albino AP. Update of prognostic and diagnostic markers in Cutaneous Malignant melanoma. Clinics Lab Med 20: 817 - 838, 2000
  • Reed JA, Finnerty, B, Albino AP. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am J Pathol 155: 549 - 555, 1999

E-mail this page to a friend